Research progress of circular RNAs in lung cancer

Cancer Biol Ther. 2019;20(2):123-129. doi: 10.1080/15384047.2018.1523848. Epub 2018 Nov 7.

Abstract

Lung cancer is one of the most common cancers and the leading cause of cancer-related death worldwide. Despite encouraging results achieved with targeted therapy in recent years, the early diagnosis and treatment of lung cancer remains a major problem. Circular RNA (circRNA), a type of RNA with covalently closed continuous loop structures, has structural stability and certain tissue specificity. Recent studies have found that circRNAs have an important role in tumor development and are expected to be revealed as new targets for tumor prediction and treatment. Research on the biological functions and regulation mechanisms of circRNAs in lung cancer is in its infancy but is gathering momentum. In this review, we discuss the properties, biogenesis, biological function, and research progress of circRNAs in lung cancer to provide a theoretical foundation and new directions for studies on circRNAs in lung cancer.

Keywords: Lung cancer; back-splicing; biogenesis; biomarkers; circular RNA; microRNA sponge; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • RNA, Circular / genetics*
  • Research Design

Substances

  • RNA, Circular

Grants and funding

This work was supported by the Liaoning Fundamental Research Funds for Universities (No. LZDK201702).